Anesth Analg 2004;98:75-80
© 2004 International Anesthesia Research Society
AMBULATORY ANESTHESIA
Spinal 2-Chloroprocaine: A Comparison with Lidocaine in Volunteers
Mary E. Kouri, MD, and
Dan J. Kopacz, MD
From the Department of Anesthesiology, Virginia Mason Medical Center, Seattle, Washington
Address correspondence to Dr. Kopacz, Department of Anesthesiology, Virginia Mason Clinic, 1100 Ninth Avenue, B2-AN, PO Box 900, Seattle, WA 98111. Address email to anedjk{at}vmmc.org
Subarachnoid lidocaine has been the anesthetic of choice for outpatient spinal anesthesia. However, its use is associated with transient neurologic symptoms (TNS). Preservative-free formulations of 2-chloroprocaine are now available and may compare favorably with lidocaine for spinal anesthesia. In this double-blinded, randomized, crossover study, we compared spinal chloroprocaine and lidocaine in 8 volunteers, each receiving 2 spinal anesthetics: 1 with 40 mg 2% lidocaine and the other with 40 mg 2% preservative-free 2-chloroprocaine. Pinprick anesthesia, tolerance to transcutaneous electrical stimulation and thigh tourniquet, motor strength, and a simulated discharge pathway were assessed. Chloroprocaine produced anesthetic efficacy similar to lidocaine, including peak block height (T8 [T511] versus T8 [T612], P = 0.8183) and tourniquet tolerance (46 ± 6 min versus 38 ± 24 min, P = 0.4897). Chloroprocaine anesthesia resulted in faster resolution of sensory (103 ± 13 min versus 126 ± 16 min, P = 0.0045) and more rapid attainment of simulated discharge criteria (104 ± 12 min versus 134 ± 14 min, P = 0.0007). Lidocaine was associated with mild to moderate TNS in 7 of 8 subjects; no subject complained of TNS with chloroprocaine (P = 0.0004). We conclude that the anesthetic profile of chloroprocaine compares favorably with lidocaine. Reliable sensory and motor blockade with predictable duration and minimal side effects make chloroprocaine an attractive choice for outpatient spinal anesthesia.
IMPLICATIONS: The spinal anesthetic profile of chloroprocaine (40 mg) compares favorably with the same dose of spinal lidocaine. Reliable sensory and motor blockade with predictable duration and minimal side effects and without signs of transient neurological symptoms make chloroprocaine an attractive choice for outpatient spinal anesthesia.
This article has been cited by other articles:

|
 |

|
 |
 
A. Casati, G. Fanelli, G. Danelli, M. Berti, D. Ghisi, M. Brivio, M. Putzu, and A. Barbagallo
Spinal Anesthesia with Lidocaine or Preservative-Free 2-Chlorprocaine for Outpatient Knee Arthroscopy: A Prospective, Randomized, Double-Blind Comparison
Anesth. Analg.,
April 1, 2007;
104(4):
959 - 964.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Casati, G. Danelli, M. Berti, A. Fioro, A. Fanelli, C. Benassi, G. Petronella, and G. Fanelli
Intrathecal 2-chloroprocaine for lower limb outpatient surgery: a prospective, randomized, double-blind, clinical evaluation.
Anesth. Analg.,
July 1, 2006;
103(1):
234 - 238.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Hadzic
Is Regional Anesthesia Really Better than General Anesthesia?
Anesth. Analg.,
December 1, 2005;
101(6):
1631 - 1633.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. T. YaDeau, G. A. Liguori, and V. M. Zayas
The Incidence of Transient Neurologic Symptoms After Spinal Anesthesia with Mepivacaine
Anesth. Analg.,
September 1, 2005;
101(3):
661 - 665.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Hadzic, P. E. Karaca, P. Hobeika, G. Unis, J. Dermksian, M. Yufa, R. Claudio, J. D. Vloka, A. C. Santos, and D. M. Thys
Peripheral Nerve Blocks Result in Superior Recovery Profile Compared with General Anesthesia in Outpatient Knee Arthroscopy
Anesth. Analg.,
April 1, 2005;
100(4):
976 - 981.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Drasner
Chloroprocaine Spinal Anesthesia: Back to the Future?
Anesth. Analg.,
February 1, 2005;
100(2):
549 - 552.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. R. Yoos and D. J. Kopacz
Spinal 2-Chloroprocaine for Surgery: An Initial 10-Month Experience
Anesth. Analg.,
February 1, 2005;
100(2):
553 - 558.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. R. Davis and D. J. Kopacz
Spinal 2-Chloroprocaine: The Effect of Added Clonidine
Anesth. Analg.,
February 1, 2005;
100(2):
559 - 565.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. R. Yoos and D. J. Kopacz
Spinal 2-Chloroprocaine: A Comparison with Small-Dose Bupivacaine in Volunteers
Anesth. Analg.,
February 1, 2005;
100(2):
566 - 572.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. F. Gonter and D. J. Kopacz
Spinal 2-Chloroprocaine: A Comparison with Procaine in Volunteers
Anesth. Analg.,
February 1, 2005;
100(2):
573 - 579.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. H. de Jong, M. E. Kouri, and D. J. Kopacz
Troubling Incidence of Lidocaine Radiculotoxicity (TNS) in Volunteers * Response
Anesth. Analg.,
October 1, 2004;
99(4):
1265 - 1266.
[Full Text]
[PDF]
|
 |
|
|